Representation of animated drawings of tumor structures sculpted from the material. Font: Nature.com Searchers has unveiled the world’s largest cancer atlas, a milestone that could change the way this complex disease is diagnosed and treated. Among the co-authors of this monumental project is Drª. Li Ding, a leading researcher in the field of cancer genetics and [...]
A scientific team from Hospital del Mar, in Barcelona, has made a discovery that could change the way we treat breast cancer. It is a type of lymphocyte (white blood cell), which appears to have a crucial role in the fight against this disease. This study, published in the Journal of Experimental & Clinical Cancer Research, [...]
A team of researchers from Osaka Metropolitan University in Japan has made an important discovery about kencur ginger, a variety of ginger that grows in Southeast Asia, concluding that it has notable anti-cancer properties. Led by Professor Akiko Kojima of the Graduate School of Human Life and Ecology, the team delved into the molecular components of [...]
Scientific teams from the Higher Council for Scientific Research (CSIC), the National Cancer Research Center (CNIO) and the Center for Applied Medical Research (CIMA), have detected the DNA repair method carried out by tumor cells to resist chemotherapy and other liver cancer treatments. To carry out this research, published in the journal “Cell Reports“, a [...]
Research staff from the Higher Council for Scientific Research (CSIC) and the Institute for Protein Design have designed and manufactured new proteins, which are not present in nature, with structures similar to the immunoglobulins of antibodies, which are the proteins used by the system immune system to identify and neutralize foreign bodies such as pathogenic [...]
A research team from the Scripps Institution of Oceanography at UC San Diego (USA) has discovered for the first time the enzymatic process that activates the molecule salinosporamide A (also called Marizomb), from a marine microorganism, which is currently in phase III clinical trials for the treatment of brain cancer. The study, published in Nature Chemical [...]
The Hospital Clínic de Barcelona-IDIBAPS has developed a new CAR-T treatment for multiple myeloma, the second most common blood cancer, with encouraging results: “all patients improve, 75% of them maintain the response and not they have disease progression at 12 months, and 60% have complete remission without residual disease “, says Dr. Fernández de Larrea, [...]
Sorry, this entry is only available in European Spanish.
